Related Experiment Videos

Lymphokines in health and disease

International Journal of Dermatology

|September 1, 1977

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.

The British journal of dermatology·2014

Diagnosing and treating psoriatic arthritis: an update.

The British journal of dermatology·2013

Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice.

The British journal of dermatology·2013

Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2012

Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial.

The British journal of dermatology·2009

See all related articles